Related Experiment Video
Updated: Jun 6, 2026
07:05
Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Published on: May 17, 2015
The pathology of chronic allograft dysfunction
Lorraine C Racusen1, Heinz Regele
1Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. lracusen@jhmi.edu
Kidney International. Supplement
|December 1, 2010
Summary
Pathologists can identify specific causes of chronic allograft dysfunction beyond general fibrosis. Early diagnosis of inflammation and fibrosis is crucial for managing kidney transplant patients and improving graft survival.
Area of Science:
- Nephrology
- Transplant Pathology
- Immunology
Background:
- Chronic allograft dysfunction (CAD) involves diverse fibrosing and sclerosing changes in kidney transplants.
- Fibrosis in CAD is multifactorial, representing a common endpoint of various injurious processes.
- Accurate pathological diagnosis is essential for understanding pathogenic mechanisms in CAD.
Purpose of the Study:
- To highlight the pathologist's role in diagnosing specific causes of CAD.
- To emphasize the importance of identifying active inflammation and fibrosis for patient management.
- To discuss the utility of various diagnostic modalities in assessing kidney allografts.
Main Methods:
- Review of diagnostic criteria for identifying specific lesions in CAD.
- Analysis of factors contributing to fibrosis, including drug toxicity, infections, hypertension, and rejection.
- Consideration of histological, immunohistological, ultrastructural, and molecular studies.
Main Results:
- Specific diagnoses, beyond 'interstitial fibrosis and tubular atrophy, no specific cause', can be made in most CAD cases.
- Persistent inflammation combined with fibrosis is strongly correlated with poor graft outcomes.
- Early identification of pathological processes through protocol biopsies can aid in managing graft deterioration.
Conclusions:
- Pathologists play a critical role in diagnosing specific etiologies of CAD, guiding therapeutic strategies.
- Recognizing active inflammation and the stage of fibrosis is vital for optimizing patient management and graft survival.
- Comprehensive diagnostic approaches, including advanced techniques and protocol biopsies, are necessary for effective CAD assessment.
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...